Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition B Dahlbäck, BO Villoutreix Arteriosclerosis, thrombosis, and vascular biology 25 (7), 1311-1320, 2005 | 296 | 2005 |
The anticoagulant protein C pathway B Dahlbäck, BO Villoutreix FEBS letters 579 (15), 3310-3316, 2005 | 286 | 2005 |
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery S Perot, O Sperandio, MA Miteva, AC Camproux, BO Villoutreix Drug discovery today 15 (15-16), 656-667, 2010 | 237 | 2010 |
FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects D Lagorce, O Sperandio, H Galons, MA Miteva, BO Villoutreix BMC bioinformatics 9 (1), 396, 2008 | 223 | 2008 |
Complement inhibitor C4b-binding protein—friend or foe in the innate immune system? AM Blom, BO Villoutreix, B Dahlbäck Molecular immunology 40 (18), 1333-1346, 2004 | 205 | 2004 |
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography S Stoilova-McPhie, BO Villoutreix, K Mertens, G Kemball-Cook, ... Blood 99 (4), 1215-1223, 2002 | 193 | 2002 |
FAF-Drugs3: a web server for compound property calculation and chemical library design D Lagorce, O Sperandio, JB Baell, MA Miteva, BO Villoutreix Nucleic acids research 43 (W1), W200-W207, 2015 | 189 | 2015 |
Rationalizing the chemical space of protein–protein interaction inhibitors O Sperandio, CH Reynès, AC Camproux, BO Villoutreix Drug discovery today 15 (5-6), 220-229, 2010 | 167 | 2010 |
Toward in silico structure-based ADMET prediction in drug discovery G Moroy, VY Martiny, P Vayer, BO Villoutreix, MA Miteva Drug discovery today 17 (1-2), 44-55, 2012 | 165 | 2012 |
A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1 NV Prasadarao, AM Blom, BO Villoutreix, LC Linsangan The Journal of Immunology 169 (11), 6352-6360, 2002 | 165 | 2002 |
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome F Bienaime, MA Dragon-Durey, CH Regnier, SC Nilsson, WH Kwan, ... Kidney international 77 (4), 339-349, 2010 | 161 | 2010 |
Structure-based virtual ligand screening: recent success stories BO Villoutreix, R Eudes, MA Miteva Combinatorial chemistry & high throughput screening 12 (10), 1000-1016, 2009 | 142 | 2009 |
Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex MA Miteva, WH Lee, MO Montes, BO Villoutreix Journal of medicinal chemistry 48 (19), 6012-6022, 2005 | 127 | 2005 |
Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site‐directed mutagenesis J Duan, B Dahlbäck, BO Villoutreix FEBS letters 499 (1-2), 127-132, 2001 | 119 | 2001 |
A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function AM Blom, J Webb, BO Villoutreix, B Dahlbäck Journal of Biological Chemistry 274 (27), 19237-19245, 1999 | 119 | 1999 |
A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells A Säfholm, K Leandersson, J Dejmek, CK Nielsen, BO Villoutreix, ... Journal of Biological Chemistry 281 (5), 2740-2749, 2006 | 112 | 2006 |
FAF-Drugs: free ADME/tox filtering of compound collections MA Miteva, S Violas, M Montes, D Gomez, P Tuffery, BO Villoutreix Nucleic acids research 34 (suppl_2), W738-W744, 2006 | 106 | 2006 |
MS-DOCK: accurate multiple conformation generator and rigid docking protocol for multi-step virtual ligand screening N Sauton, D Lagorce, BO Villoutreix, MA Miteva BMC bioinformatics 9 (1), 184, 2008 | 105 | 2008 |
Free resources to assist structure-based virtual ligand screening experiments BO Villoutreix, N Renault, D Lagorce, O Sperandio, M Montes, MA Miteva Current Protein and Peptide Science 8 (4), 381-411, 2007 | 104 | 2007 |
Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods C Reynès, H Host, AC Camproux, G Laconde, F Leroux, A Mazars, ... PLoS computational biology 6 (3), e1000695, 2010 | 103 | 2010 |